CA2531948C - Forme cristallisee de n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide - Google Patents

Forme cristallisee de n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide Download PDF

Info

Publication number
CA2531948C
CA2531948C CA2531948A CA2531948A CA2531948C CA 2531948 C CA2531948 C CA 2531948C CA 2531948 A CA2531948 A CA 2531948A CA 2531948 A CA2531948 A CA 2531948A CA 2531948 C CA2531948 C CA 2531948C
Authority
CA
Canada
Prior art keywords
modification
water
formula
organic solvent
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2531948A
Other languages
English (en)
Other versions
CA2531948A1 (fr
Inventor
Holger Faasch
Udo Hedtmann
Uwe Westenfelder
Erich Paulus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19734438A external-priority patent/DE19734438A1/de
Priority claimed from DE1997156093 external-priority patent/DE19756093A1/de
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Priority claimed from CA002245267A external-priority patent/CA2245267C/fr
Publication of CA2531948A1 publication Critical patent/CA2531948A1/fr
Application granted granted Critical
Publication of CA2531948C publication Critical patent/CA2531948C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2531948A 1997-08-08 1998-08-07 Forme cristallisee de n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide Expired - Lifetime CA2531948C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19734438.0 1997-08-08
DE19734438A DE19734438A1 (de) 1997-08-08 1997-08-08 Kristallform von N-(4-Trifluormethylphenyl)-5-methyl-isoxazole-4-carboxamid
DE1997156093 DE19756093A1 (de) 1997-12-17 1997-12-17 Verfahren zur Herstellung einer Kristallform von N-(4-Trifluormethylphenyl)-5-methyl-isoxazole-4-carboxamid
DE19756093.8 1997-12-17
CA002245267A CA2245267C (fr) 1997-08-08 1998-08-07 Forme cristallisee de n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002245267A Division CA2245267C (fr) 1997-08-08 1998-08-07 Forme cristallisee de n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide

Publications (2)

Publication Number Publication Date
CA2531948A1 CA2531948A1 (fr) 1999-02-08
CA2531948C true CA2531948C (fr) 2011-07-12

Family

ID=36121816

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2531948A Expired - Lifetime CA2531948C (fr) 1997-08-08 1998-08-07 Forme cristallisee de n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide

Country Status (1)

Country Link
CA (1) CA2531948C (fr)

Also Published As

Publication number Publication date
CA2531948A1 (fr) 1999-02-08

Similar Documents

Publication Publication Date Title
CA2245267C (fr) Forme cristallisee de n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
EP0490648B1 (fr) Agents pharmaceutiques
CA2531948C (fr) Forme cristallisee de n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
WO2007017897A2 (fr) Nouvelles formes cristallines de (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine
AU3095600A (en) New pharmaceutical formulation
EP3004104A1 (fr) Forme cristalline de n,n-dicyclopropyl-4-(1,5-diméthyl-1h-pyrazol-3-ylamino)-6-éthyl-1-méthyl-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide pour le traitement de troubles myéloprolifératifs
HK1017681B (en) Crystal from of n-(4-trifluoromethylphenyl)-5-methylisox
DE19734438A1 (de) Kristallform von N-(4-Trifluormethylphenyl)-5-methyl-isoxazole-4-carboxamid
BR112021022335B1 (pt) Formas cristalinas de n-(3-(2-(2-hidroxietoxi)-6-morfolinopiridin4-il)-4- metilfenil)-2 (trifluorome-til)isonicotinamida como inibidores raf, seus usos, e composição farmacêutica

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20180807